BRINGING REJUVENATION BIOTECHNOLOGY AND INVESTORS TOGETHER
At the Frederick P. Rose Auditorium, Cooper Union in New York City, we will be hosting a special one-day conference focused on aging research and biotech investment. Developing therapies from initial concepts, through clinical testing, and ultimately to market takes a pipeline, and right now, that pipeline is being built to support the next step in medicine: rejuvenation biotechnology. Join us for this exciting event, where industry experts will be sharing their insights on the advances and investment prospects in an industry poised to revolutionize medicine forever.
OFFICIAL EVENT SPONSORS
The event is over and you can watch the entire event below.
Steve serves on the LEAF Board of Directors and is the Editor in Chief, coordinating the daily news articles and social media content of the organization. He is an active journalist in the aging research and biotechnology field and has to date written over 600 articles on the topic, interviewed over 100 of the leading researchers in the field, hosted livestream events focused on aging, as well as attending various medical industry conferences.
His work has been featured in H+ magazine, Psychology Today, Singularity Weblog, Standpoint Magazine, Swiss Monthly, Keep me Prime, and New Economy Magazine.
Steve is one of three recipients of the 2020 H+ Innovator Award and shares this honour with Mirko Ranieri – Google AR and Dinorah Delfin – Immortalists Magazine. The H+ Innovator Award looks into our community and acknowledges ideas and projects that encourage social change, achieve scientific accomplishments, technological advances, philosophical and intellectual visions, author unique narratives, build fascinating artistic ventures, and develop products that bridge gaps and help us to achieve transhumanist goals.
Steve has a background in project management and administration which has helped him to build a united team for effective fundraising and content creation, while his additional knowledge of biology and statistical data analysis allows him to carefully assess and coordinate the scientific groups involved in the project.
On this episode of Lifespan News, Ryan O’Shea shows how the A4LI brings both major U.S. political parties together to fight aging. Script The newly launched Alliance for Longevity Initiatives, an organization […]
Dr. Brian Kennedy is a longevity heavyweight: a former President of the Buck Institute, currently a Distinguished Professor in the Department of Biochemistry and […]
On this episode of Science to Save the World, we discuss the relationship of cryptocurrencies and longevity, focusing on VitaDAO and related innovations. […]
A study published in Cell Reports has found α-synuclein, the fundamental protein of Parkinson’s disease, to be critical in immune function. The gut-brain axis as a channel for disease Parkinson’s disease, […]
93% of the world’s money is now digital, held in virtual ledgers across banks and other financial institutions. With the increasing digitalization of financial services, there is no doubt that we are heading for […]
An outcomes study conducted by the Diabetes Prevention Program (DPP) has examined the effects of lifestyle interventions and the popular diabetes drug metformin on all-cause mortality. […]
A recent study published in Biogerontology has discovered a potential new aging biomarker and longevity therapeutic target [1]. Isthmin 1 (Ism1) in aging fish Ism1 is not a well-known […]
Scientists have created genetically engineered T cells that target activated cardiac fibroblasts in a transient manner, alleviating symptoms of cardiac injury [1]. Engineered immune cells CAR T cell therapy is a much-touted novel technique […]
Write a comment: